Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$201K Buy
1,952
+139
+8% +$14.9K 0.12% 163
2022
Q1
$204K Sell
1,813
-2,668
-60% -$314K 0.06% 328
2021
Q4
$571K Sell
4,481
-38
-0.8% -$4.7K 0.14% 156
2021
Q3
$521K Buy
4,519
+870
+24% +$104K 0.13% 181
2021
Q2
$445K Buy
+3,649
New +$445K 0.1% 207

Other funds holding EME

Exane Derivatives's EME Position: Q2 2022 in Review

Exane Derivatives increased its Emcor (EME) stake by 7.7% in Q2 2022, buying an estimated $14.9K and bringing the position to 1,952 shares worth $201K. The position accounts for 0.12% of the portfolio, ranked #163.

Exane Derivatives first reported a position in EME in Q2 2021 and has held it in 5 quarters since. The position peaked at $571K in Q4 2021. 382 funds tracked by Wall St. Rank hold EME as of Q2 2022.

  • Exane Derivatives held 1,952 shares of Emcor worth $201K as of Q2 2022.
  • Exane Derivatives bought 139 Emcor shares in Q2 2022, an estimated $14.9K.
  • Emcor made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #163 holding.
  • Exane Derivatives first reported a position in Emcor in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Emcor position peaked at $571K in Q4 2021.
  • 382 funds tracked by Wall St. Rank held Emcor as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.